Direct Rx FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection NAI · Jun 4, 2026
  • No warning letters matched by name
Inspections 3 0 OAI
Recalls 38 0 Class I (0%)
Warning letters 0 None on file
510(k) clearances 0 None on file

Direct Rx has 38 FDA recalls, 3 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Direct Rx" is on file.

What these totals cover: FDA records filed under the name "Direct Rx".

Latest recall
D-0107-2027 · Class II · Sep 29, 2026
Latest inspection
Jun 4, 2026 · NAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls38Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections3Nov 16, 2026Newest record Nov 5, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Direct Rx's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Direct Rx: FDA inspections per year

2017: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 2 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 3 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 3 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 10 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 14 recall records (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 3 recall records (0 Class I) 2026: 1 inspection (0 OAI), 0 warning letters, 2 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202610020
202500030
202400010
2023000140
2022000100
202100030
202000030
201900020
201800000
201710000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Direct Rx as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Direct Rx yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent recalls

38 recall records from Mar 12, 2019 to Sep 29, 2026. Showing the 20 most recent. View all 38 recall records

NumberClassProductDate
D-0107-2027Class IILidocaine Ointment USP, 5.0 % 50g JAR, Rx only, Packaged and Distributed by: Direct Rx Dawsonville…Sep 29, 2026
D-0617-2026Class IIDULOXETINE D/R, a) 30 mg (NDC 61919-482-30), 30 Caps; b) 30 mg (NDC 61919-482-60), 60 Caps…Jun 22, 2026
D-0567-2025Class IIDuloxetine D/R, 20 mg, 30 Caps, 30-count bottle, RX Only, Packaged & Distributed by: Direct Rx…Mar 7, 2025
D-0568-2025Class IIDuloxetine D/R, 30 mg, 30 Caps, RX Only, Packaged as a) 30-count bottle NDC 61919-0482-30, b)…Mar 7, 2025
D-0364-2025Class IICIPROFLOXACIN OPHTH SOLUTION, 0.3% 5mL bottle, Rx Only, Generic for CILOXAN, Packaged and…Jan 31, 2025
D-0041-2025Class IIIbuprofen 800mg, Generic for: Motrin, Each tablet contains: Ibuprofen, USP 800 mg, Packaged and…Aug 9, 2024
D-0509-2023Class IIAlprazolam C-IV, 2 mg, 60 Tabs per bottle, Rx only, Packaged and Distributed By: Direct Rx…Mar 22, 2023
D-0507-2023Class IIAlprazolam C-IV, 0.5 mg, 30 Tabs per bottle, Rx only, Packaged and Distributed By: Direct Rx…Mar 22, 2023
D-0508-2023Class IIAlprazolam C-IV, 1 mg, packaged in a) 30 Tabs per bottle, NDC 72189-213-30; b) 60 Tabs per bottle…Mar 22, 2023
D-0480-2023Class IIGlimepiride, USP, 1 mg Tablets, Rx Only, Packaged as a a) 30-count bottle, NDC 61919-0723-30; b)…Mar 13, 2023
D-0484-2023Class IISimvastatin, USP, 10 mg Tablets, Rx Only, Packaged as a a) 30-count bottle, NDC 61919-0688-30 b)…Mar 13, 2023
D-0479-2023Class IIRopinirole, USP, 1 mg Tablets, Rx Only, Packaged as a 30-count bottle, NDC 72189-0364-30; Packaged…Mar 13, 2023
D-0477-2023Class IIFinasteride, USP, 5 mg Tablets, Rx Only, Packaged as a 90-count bottle, NDC 61919-0733-90; Packaged…Mar 13, 2023
D-0483-2023Class IISimvastatin, USP, 5 mg Tablets, Rx Only, Packaged as a 90-count bottle, NDC 61919-0710-90 Packaged…Mar 13, 2023
D-0478-2023Class IIRopinirole, USP, 0.25 mg Tablets, Rx Only, Packaged as a 30-count bottle, NDC 72189-0364-30…Mar 13, 2023
D-0486-2023Class IISimvastatin, USP, 40 mg, Rx Only, Packaged as a 90-count bottle, NDC 61919-0431-90, Packaged and…Mar 13, 2023
D-0481-2023Class IIGlimepiride, USP, 2 mg Tablets, Rx Only, Packaged as a a) 30-count bottle, NDC 61919-0488-30; b)…Mar 13, 2023
D-0482-2023Class IIGlimepiride, USP, 4 mg Tablets, Rx Only, Packaged as a a) 30-count bottle, NDC 61919-0250-30; b)…Mar 13, 2023
D-0485-2023Class IISimvastatin, USP, 20 mg Tablets, Rx Only, Packaged as a a) 30-count bottle, NDC 61919-0446-30 b)…Mar 13, 2023
D-0476-2023Class IIMontelukast Sodium Tablets, USP, 10 mg Tablets, Rx Only, Packaged as: a) 30-count bottle, NDC…Mar 13, 2023

Recent FDA inspections

3 inspections from Aug 13, 2015 to Jun 4, 2026.

DateSiteProductClassificationFEI
Jun 4, 2026Dawsonville, GADrugsNo Action Indicated (NAI)3011690045
Dec 15, 2017Dawsonville, GADrugsNo Action Indicated (NAI)3011690045
Aug 13, 2015Dawsonville, GADrugsVoluntary Action Indicated (VAI)3011690045
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3011690045Dawsonville, GA3Jun 4, 2026

Direct Rx and the FDA: common questions

Has Direct Rx received an FDA warning letter?

No FDA warning letter addressed to the name "Direct Rx" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Direct Rx received an FDA Form 483?

FDA has not published a Form 483 for "Direct Rx" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Direct Rx?

The most recent FDA inspection on file ended Jun 4, 2026 at Dawsonville, GA and was classified NAI. FDA has 3 inspections of Direct Rx on file.

Has Direct Rx had an FDA recall?

Yes. Direct Rx has 38 FDA recalls on record. The most recent started Sep 29, 2026.

Need more than this page shows? Ask about Direct Rx in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.